Oregon Public Employees Retirement Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
31,235
+2,152
+7% +$954K 0.17% 91
2026
Q1
$13M Buy
29,083
+39
+0.1% +$18.2K 0.17% 93
2025
Q4
$13.2M Sell
29,044
-241
-0.8% -$104K 0.17% 96
2025
Q3
$11.5M Buy
29,285
+7,101
+32% +$2.97M 0.15% 107
2025
Q2
$9.88M Buy
22,184
+100
+0.5% +$46.1K 0.17% 92
2025
Q1
$10.7M Buy
22,084
+10
+0% +$4.66K 0.21% 82
2024
Q4
$8.89M Sell
22,074
-9
-0% -$4.17K 0.16% 93
2024
Q3
$10.3M Sell
22,083
-90
-0.4% -$43.2K 0.19% 80
2024
Q2
$10.4M Buy
22,173
+100
+0.5% +$43.4K 0.21% 79
2024
Q1
$9.23M Sell
22,073
-15,415
-41% -$6.52M 0.18% 87
2023
Q4
$15.3M Sell
37,488
-12,556
-25% -$4.64M 0.27% 63
2023
Q3
$17.4M Sell
50,044
-14,436
-22% -$5.05M 0.24% 93
2023
Q2
$22.7M Sell
64,480
-30,087
-32% -$10.1M 0.27% 80
2023
Q1
$29.8M Sell
94,567
-278
-0.3% -$83.4K 0.37% 55
2022
Q4
$27.4M Buy
94,845
+14,571
+18% +$4.44M 0.35% 57
2022
Q3
$23.2M Sell
80,274
-3,742
-4% -$1.08M 0.33% 53
2022
Q2
$23.7M Buy
84,016
+63,550
+311% +$17M 0.36% 51
2022
Q1
$5.34M Sell
20,466
-574
-3% -$136K 0.05% 363
2021
Q4
$4.62M Sell
21,040
-609
-3% -$118K 0.05% 319
2021
Q3
$3.93M Sell
21,649
-296
-1% -$57.8K 0.04% 350
2021
Q2
$4.42M Sell
21,945
-2,661
-11% -$557K 0.05% 338
2021
Q1
$5.29M Sell
24,606
-119
-0.5% -$26.1K 0.06% 274
2020
Q4
$5.84M Sell
24,725
-40,254
-62% -$9.24M 0.08% 238
2020
Q3
$17.7M Sell
64,979
-4,529
-7% -$1.25M 0.26% 77
2020
Q2
$20.2M Sell
69,508
-9,969
-13% -$2.7M 0.3% 62
2020
Q1
$18.9M Buy
79,477
+55,018
+225% +$12.6M 0.33% 65
2019
Q4
$5.36M Sell
24,459
-1,425
-6% -$288K 0.07% 265
2019
Q3
$4.38M Sell
25,884
-1,267
-5% -$224K 0.06% 340
2019
Q2
$4.98M Buy
27,151
+159
+0.6% +$27.8K 0.07% 298
2019
Q1
$4.96M Sell
26,992
-833
-3% -$154K 0.07% 259
2018
Q4
$4.61M Buy
27,825
+100
+0.4% +$17.3K 0.07% 248
2018
Q3
$5.34M Hold
27,725
0.07% 261
2018
Q2
$4.71M Buy
27,725
+1,136
+4% +$176K 0.07% 280
2018
Q1
$4.33M Buy
26,589
+53
+0.2% +$8.66K 0.07% 311
2017
Q4
$3.98M Hold
26,536
0.06% 332
2017
Q3
$4.04M Buy
26,536
+743
+3% +$112K 0.07% 326
2017
Q2
$3.32M Hold
25,793
0.06% 374
2017
Q1
$2.82M Hold
25,793
0.06% 360
2016
Q4
$1.9M Buy
25,793
+567
+2% +$46.1K 0.04% 473
2016
Q3
$2.2M Buy
25,226
+32
+0.1% +$3.02K 0.05% 409
2016
Q2
$2.17M Buy
25,194
+200
+0.8% +$17.3K 0.05% 421
2016
Q1
$1.99M Buy
24,994
+836
+3% +$75.6K 0.05% 455
2015
Q4
$3.04M Hold
24,158
0.07% 280
2015
Q3
$2.52M Sell
24,158
-100
-0.4% -$12.8K 0.06% 338
2015
Q2
$3M Buy
24,258
+600
+3% +$75.6K 0.07% 299
2015
Q1
$2.79M Buy
23,658
+400
+2% +$47.9K 0.06% 322
2014
Q4
$2.76M Buy
23,258
+158
+0.7% +$17.8K 0.07% 316
2014
Q3
$2.59M Buy
23,100
+300
+1% +$28.6K 0.06% 313
2014
Q2
$2.16M Buy
22,800
+400
+2% +$28K 0.05% 389
2014
Q1
$1.58M Buy
22,400
+100
+0.4% +$7.92K 0.04% 511
2013
Q4
$1.66M Sell
22,300
-13,935
-38% -$970K 0.04% 462
2013
Q3
$2.75M Sell
36,235
-10,800
-23% -$859K 0.11% 188
2013
Q2
$3.76M Buy
+47,035
New +$3.46M 0.16% 134

Other funds holding VRTX

Oregon Public Employees Retirement Fund's VRTX Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Vertex Pharmaceuticals (VRTX) stake by 7.4% in Q2 2026, buying an estimated $954K and bringing the position to 31,235 shares worth $15.5M. The position accounts for 0.17% of the portfolio, ranked #91.

Oregon Public Employees Retirement Fund first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.8M in Q1 2023. 650 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 31,235 shares of Vertex Pharmaceuticals worth $15.5M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 2,152 Vertex Pharmaceuticals shares in Q2 2026, an estimated $954K.
  • Vertex Pharmaceuticals made up 0.17% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #91 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Oregon Public Employees Retirement Fund's Vertex Pharmaceuticals position peaked at $29.8M in Q1 2023.
  • 650 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.